Pseudomonas aeruginosa Susceptibility Patterns and Associated Clinical Outcomes in People with Cystic Fibrosis following Approval of Aztreonam Lysine for Inhalation

The approval of aztreonam lysine for inhalation solution (AZLI) raised concerns that additional antibiotic exposure would potentially affect the susceptibility profiles of Pseudomonas aeruginosa isolates from cystic fibrosis (CF) patients. This 5-year, prospective, observational study tracked suscep...

Descripción completa

Detalles Bibliográficos
Autores principales: Keating, Claire L., Zuckerman, Jonathan B., Singh, Pradeep K., McKevitt, Matthew, Gurtovaya, Oksana, Bresnik, Mark, Marshall, Bruce C., Saiman, Lisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Susceptibility
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092527/
https://www.ncbi.nlm.nih.gov/pubmed/33318007
http://dx.doi.org/10.1128/AAC.02327-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092527/
https://www.ncbi.nlm.nih.gov/pubmed/33318007
http://dx.doi.org/10.1128/AAC.02327-20

Ejemplares similares